Eppendorf
Eppendorf is a leading life-science company that develops and sells instruments, consumables, and services for liquid-, sample-, and cell handling.
Eppendorf is a leading life-science company that develops and sells instruments, consumables, and services for liquid-, sample-, and cell handling. Its portfolio includes pipettes and automated pipetting systems, mixers, spectrometers, and DNA amplification equipment, bioreactors, CO2 incubators, shakers, and cell manipulation systems. Consumables such as pipette tips, plates, and disposable bioreactor vessels complement the range of premium products.
Eppendorf
102 Motor Parkway,
Hauppauge, NY 11788
custserv@eppendorf.com
tel. 800.645.3050
Pittcon Booth #: 2319
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
The Role of Forced Degradation in Method Development, Manufacturability, and CMC Strategy
April 28th 2025Forced degradation studies are critical in biologics development, particularly for monoclonal antibodies (mAbs). These studies simulate long-term environmental stressors to uncover degradation pathways and ensure the stability of critical quality attributes (CQAs), aiding in robust chemistry, manufacturing, and controls (CMC) strategies and regulatory compliance.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
